Core Insights - The report highlights that in 2024, the total salary of A-share listed company secretaries reached 4.086 billion yuan, with an average annual salary of 754,300 yuan [1] - A total of 1,144 company secretaries earned over 1 million yuan, accounting for more than 21% of the total [1] Salary Distribution - The average annual salary for company secretaries in the medical and healthcare services sector is 839,200 yuan [2] - The distribution of salaries shows that 24% earn below 500,000 yuan, 48% earn between 500,000 and 1 million yuan, and 28% earn above 1 million yuan [2] - The top three highest-paid company secretaries are Gilbert Shing Chung Li from Kanglong Chemical with 1.9855 million yuan, Gao Dapeng from Zhaoyan New Drug with 1.7384 million yuan, and Xu Xiangke from Kailaiying with 1.6114 million yuan [2] Age and Education Distribution - Company secretaries aged 40 and below constitute 43% of the market, while those aged 50 and above account for 22% [1] - The educational background of company secretaries shows that 34% hold a bachelor's degree, 52% have a master's degree, and 14% possess a doctoral degree [1] - Among the doctoral degree holders, there are 7 individuals, with the only full-time doctoral company secretary in the industry being Cao Nai'en from Huaxia Eye Hospital [1]

新里程健康科技集团股份有限公司 简式权益变动报告书 信息披露义务人：阙文彬 住所/通讯地址：成都市武侯区人民南路四段 46 号 股份变动性质：股份减少（司法拍卖导致被动减持） 签署日期：二〇二五年八月七日 上市公司：新里程健康科技集团股份有限公司 上市地点：深圳证券交易所 股票简称：新里程 股票代码：002219 二、依据上述法律法规的规定，本报告书已全面披露信息披露义务人在新里 程拥有权益的股份；截至本报告书签署之日，除本报告书披露的持股信息外，信 息披露义务人没有通过任何其他方式增加或减少其在新里程拥有权益。 三、信息披露义务人签署本报告书已获得必要的授权和批准。 四、本次权益变动是根据本报告书所载明的资料进行的。信息披露义务人没 有委托或授权任何其他人提供未在本报告书中所列载的信息或对本报告书做出 任何解释或者说明。 五、信息披露义务人保证本报告书内容的真实性、准确性、完整性，承诺其 中不存在虚假记载、误导性陈述或重大遗漏。 1 释义 在本简式权益变动报告书中，除非另有说明，下列简称具有如下含义： | | 信息披露义务人声明 | 1 | | --- | --- | --- | | | 释义 | 2 | ...

Core Insights - As of August 6, a total of 117 stocks in the Shanghai and Shenzhen markets have experienced net financing inflows for five consecutive days or more [1] - The stocks with the longest streak of net financing inflows are Chengdi Xiangjiang and Huicheng Environmental Protection, both achieving 18 consecutive trading days of net inflows [1] - Other notable stocks with significant net financing inflows include Juhe Materials (15 days), China Baoan (12 days), Jiuri New Materials, New Mileage, Jichuan Pharmaceutical, Cangge Mining, Tianzhihang, and Zhejiang Jiaoke, each with 10 to 11 consecutive trading days of net inflows [1]

Group 1 - The stock price of Xinlicheng as of August 6, 2025, is 2.16 yuan, down 0.02 yuan or 0.92% from the previous trading day [1] - The opening price on the same day was 2.17 yuan, with a high of 2.19 yuan and a low of 2.14 yuan, and the trading volume reached 661,700 hands with a transaction amount of 143 million yuan [1] - Xinlicheng operates in sectors including medical services, Gansu region, and mergers and acquisitions, with its main business covering the healthcare service field [1] Group 2 - As of July 31, 2025, the number of shareholders in Xinlicheng is 67,100, a decrease of 1,011 or 1.48% from the previous period [1] - The number of shares held by the Shenzhen Stock Connect is 16.6286 million, accounting for 0.49% of the circulating share capital [1] - On August 6, 2025, the net inflow of main funds was 3.8677 million yuan, representing 0.05% of the circulating market value, while the net outflow over the past five days was 47.0684 million yuan, accounting for 0.67% of the circulating market value [1]

（文章来源：证券日报） 证券日报网讯新里程8月6日在互动平台回答投资者提问时表示，截至2025年7月31日收盘，公司股东人 数为67112户。 ...

Core Insights - As of August 5, a total of 116 stocks in the Shanghai and Shenzhen markets have experienced net financing inflows for five consecutive days or more [1] - The stocks with the longest consecutive net inflow days are Huicheng Environmental Protection and Chengdi Xiangjiang, both achieving 17 consecutive trading days of net inflows [1] - Other notable stocks with significant consecutive net inflow days include Gaomei Co., Juhe Materials, China Baoan, Langkun Technology, Jichuan Pharmaceutical, Jiuri New Materials, Xinlicheng, Cangge Mining, Tianzhihang, and Jingcheng Co., with inflow days ranging from 9 to 15 [1]

Group 1 - A total of 107 stocks in the Shanghai and Shenzhen markets have experienced net financing inflows for 5 consecutive days or more as of August 4 [1] - The stocks with the longest consecutive net inflows are Chengdi Xiangjiang and Huicheng Environmental Protection, both achieving 16 consecutive trading days of net inflows [1] - Other notable stocks with significant consecutive net inflows include Gaocai Co., Ltd. (14 days), Juhe Materials (13 days), Juchen Co., Ltd. (12 days), China Baoan (10 days), Hongrun Construction (9 days), Jiurichuang New Materials (9 days), New Mileage (9 days), Jichuan Pharmaceutical (9 days), and Langkun Technology (9 days) [1]

Core Viewpoint - New Mile's stock closed at 2.18 yuan on August 4, down 1.80%, with a rolling PE ratio of 65.86 times and a total market value of 7.384 billion yuan [1] Group 1: Company Overview - New Mile Health Technology Group Co., Ltd. specializes in medical services and pharmaceutical manufacturing, focusing on drug production for over 20 years [1] - The company's main products include pharmaceuticals and medical services, with the "Duyiwei" brand as its core series of traditional Chinese medicine [1] - "Duyiwei Capsule" is included in the 2020 edition of the "Chinese Pharmacopoeia" and is recognized as a national basic drug, featuring unique efficacy, high safety, and low treatment costs [1] Group 2: Financial Performance - In the first quarter of 2025, the company reported operating revenue of 796 million yuan, a year-on-year decrease of 16.49%, and a net profit of 25.652 million yuan, down 9.35% year-on-year, with a gross profit margin of 27.96% [1] Group 3: Industry Comparison - The average PE ratio for the medical services industry is 47.79 times, with a median of 59.03 times, placing New Mile at the 32nd position in the industry ranking [2] - The company's static PE ratio is 64.34 times, and its price-to-book ratio is 3.66 times [2]

证券之星消息，8月4日医疗服务板块较上一交易日下跌0.26%，昭衍新药领跌。当日上证指数报收于 3583.31，上涨0.66%。深证成指报收于11041.56，上涨0.46%。医疗服务板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | | 成交额(元) | | --- | --- | --- | --- | --- | --- | --- | | 688265 | 南模生物 | 43.73 | 20.01% | | 4.08万 | 1.66亿 | | 688621 | 阳光诺和 | 66.54 | 14.84% | | 12.60万 | 8.15亿 | | 301201 | 诚达药业 | 28.10 | 4.04% | | 10.58万 | 2.93亿 | | 688222 | 成都先导 | 24.74 | 3.82% | | 33.55万 | 7.91亿 | | 002172 | 澳洋健康 | 4.25 | 3.41% | | 70.07万 | 2.93亿 | | 688046 | 药康生物 | 16.41 | 3.01% | | 4.55万 | 7293.23万 | | ...

从股票走势来看，新里程近一年上涨 24.02%。 来源：金融界 资料显示，新里程健康科技集团股份有限公司的主营业务是医疗服务及医药工业。公司的主要产品是药 品及医疗产品、医疗服务。公司专注于药品生产二十余载，形成了以"独一味"品牌为核心的系列中成 药，其中"独一味胶囊"收载于《中国药典》（2020年版），为2018年版国家基药、全国独家品种、中成 药优质优价产品、国家医保目录品种，具有独特疗效、安全性高、治疗成本低的优势。"独一味"商标为 中国驰名商标。公司董事长为许铭桂。 金融界消息，根据中登公司数据显示，截至上周最后一个交易日（8月1日），新里程股东质押比例占总 股本14.36%，位居两市第631位。 数据显示，新里程股东共质押4.87亿股，分为13笔，其中无限售股4.87亿股，质押总市值10.80亿元。 ...